Home › Non-Small Cell Lung Cancer › Florida › Deltona

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Deltona, FL

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Deltona. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Nagre-recruitPhase 1/2

Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06772623

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Nagre-recruitPhase 3

Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Alpha Clinical Research Centers LLC, Orange City · 4 mi ang layo
Florida Cancer Specialists, Orange City · 4 mi ang layo
Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Nagre-recruitPhase 3

Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06758401

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Nagre-recruitPhase 1/2

Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227298

Pan-tumor MRD Study

Nagre-recruitObservasyonal na pag-aaral

Mid Florida Cancer Centers, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06605404

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Nagre-recruitPhase 3

Research Site, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06357533

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Nagre-recruitPhase 3

Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06875310

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3

Mid Florida Cancer Centers, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Nagre-recruitPhase 3

Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07195695

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Nagre-recruitPhase 2/3

Local Institution - 007-926-B, Daytona Beach · 26 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04613596

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Nagre-recruitPhase 3

Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06899126

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Nagre-recruitPhase 3

Research Site, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06350097

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Nagre-recruitPhase 1/2

Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Nagre-recruitPhase 2

Mid Florida Hematology and Oncology Center, Orange City · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06463665

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Deltona

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.